Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml - HSA Drug Approval Details

Approvals/HSA/AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml

Approved

THERAPEUTIC

AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml

KOTRA PHARMA (M) SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Dec 11, 1998
Approval ID: cab79d7de0b3e3f9
Company: KOTRA PHARMA (M) SDN BHD
Type: Therapeutic

Approval Details

Approval Id: cab79d7de0b3e3f9
Drug Name: AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml
Product Name: AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml
Approval Number: SIN10539P
Approval Date: 1998-12-11
Registrant: KOTRA PHARMA MARKETING
Licence Holder: KOTRA PHARMA MARKETING
Drug Type: Therapeutic
Forensic Classification: Pharmacy Only
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: R06AD02
Atc Item Name: promethazine
Pharma Manufacturer Name: KOTRA PHARMA MARKETING
Company Detail Path: /organization/kotra-pharma-marketing

Active Ingredients

PROMETHAZINE HCl

5 mg/5 ml

PROMETHAZINE HCL

5 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Dec 11, 1998

Approval ID

cab79d7de0b3e3f9

Type

Therapeutic

Back to HSA Approvals